Stahl's Essential Psychopharmacology Online
In Collaboration With
Original release date: March 2008
Reviewed and re-released: March 2011
CME credit expiration date: for re-released version February 2014 (if this date has passed, please contact NEI for updated information)
This activity was designed for health care professionals, including psychiatrists, neurologists, primary care physicians, pharmacists, psychologists, nurses, and others, who treat patients with psychiatric conditions.
The content of this educational activity was determined by rigorous assessment, including activity feedback, expert faculty assessment, literature review, and new medical knowledge, which revealed the following unmet needs:
Psychiatric illnesses have a neurobiological basis and are primarily treated by pharmacological agents; understanding each of these, as well as the relationship between them, is essential in order to select appropriate treatment for a patient
The field of psychopharmacology has experienced incredible growth; it has also experienced a major paradigm shift from a limited focus on neurotransmitters and receptors to an emphasis on brain circuits, neuroimaging, genetics, and signal transduction cascades
Upon completion of this activity, you should be able to:
Apply neurobiologic and mechanistic evidence when selecting treatment strategies in order to match treatment to the individual needs of the patient
Utilize new scientific data to modify existing treatment strategies in order to improve patient outcomes
The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Neuroscience Education Institute designates this enduring material for a maximum of 90.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is in the form of a printed book and incorporates instructional design to enhance your retention of the information and pharmacological concepts presented. You are advised to go through the figures in this activity from beginning to end, followed by the text, and then complete the posttests and evaluations. The estimated time for completion of this activity is 90 hours.
Certificates of CME credit or participation are available for each topical section of the book (total of twelve sections). To receive a section-specific certificate, please complete the relevant posttest (you must score at least 70% to receive credit) and section evaluation available online only at http://www.neiglobal.com/ep3. If a score of 70% or more is attained, you can immediately print your certificate. There is a fee for each certificate (varies per section).
It is the policy of the Neuroscience Education Institute to ensure balance, independence, objectivity, and scientific rigor in its educational activities. The Neuroscience Education Institute takes responsibility for the content, quality, and scientific integrity of this CME activity.
All faculty participating in any NEI-sponsored educational activity and all individuals in a position to influence or control content development are required by NEI to disclose to the activity audience any financial relationships or apparent conflicts of interest that may have a direct bearing on the subject matter of the activity. Although potential conflicts of interest are identified and resolved prior to the activity, it remains for the audience to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.
Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.
Stephen M. Stahl, MD, PhD
Adjunct Professor, Department of Psychiatry
University of California, San Diego School of Medicine, San Diego, CA
Dr. Stahl has been a consultant, board member, or on the speakers bureau for the following pharmaceutical companies within the last three years: Acadia, Alkermes, Amylin, Asahi Kasei, Astra Zeneca, Avera, Azur, Biovail, Boehringer Ingelheim, BristolMyers Squibb, Cephalon, CSC Pharmaceuticals, Cyberonics, Cypress Bioscience, Dainippon, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Jazz Pharmaceuticals, Labopharm, Lundbeck, Neurocrine Biosciences, NeuroMolecular, Neuronetics, Novartis, Organon, Pamlab, Pfizer, Pierre Fabre, sanofi-aventis, Schering-Plough, Sepracor, Shire, SK Corporation, Solvay, Somaxon, Takeda, Tethys, Tetragenix, Vanda Pharmaceuticals, and Wyeth.
Meghan Grady
Director, Content Development
Neuroscience Education Institute, Carlsbad, CA
No other financial relationships to disclose.
Nancy Muntner
Director, Medical Illustrations
Neuroscience Education Institute, Carlsbad, CA
No other financial relationships to disclose.
Disclosed financial relationships have been reviewed by the Neuroscience Education Institute CME Advisory Board to resolve any potential conflicts of interest. All faculty and planning committee members have attested that their financial relationships do not affect their ability to present well-balanced, evidence-based content for this activity.
This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. Please consult the product prescribing information for full disclosure of labeled uses.
Participants have an implied responsibility to use the newly acquired information from this activity to enhance patient outcomes and their own professional development. The information presented in this educational activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this educational activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Primary references and full prescribing information should be consulted.
Sponsored by Neuroscience Education Institute
This activity is supported solely by the sponsor, Neuroscience Education Institute.